Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

tranilast MeSH Supplementary Concept Data 2025


MeSH Supplementary
tranilast
Unique ID
C012293
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C012293
Entry Term(s)
1 N-(3'-4'-dimethoxycinnamoyl) anthranilic acid (N-5'), N(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5')
2-((3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid
MK-341
MK341
N (3', 4'-dimethoxycinnamoyl) anthranilic acid (N-5')
N-(3',4'-dimethoxycinnamoyl)anthranilic acid
Rizaben
tranilast hydrate
tranilast sodium salt
Pharm Action
Anti-Inflammatory Agents, Non-Steroidal
Calcium Channel Blockers
Histamine H1 Antagonists
Platelet Aggregation Inhibitors
Anti-Allergic Agents
Registry Numbers
HVF50SMY6E
104931-56-8
134956-04-0
0
Related Numbers
104931-56-8
134956-04-0
53902-12-8
Heading Mapped to
*ortho-Aminobenzoates
Frequency
537
Note
antiallergic drug; potent inhibitor of homologous passive cutaneous anaphylaxis
Source
Allergy 1979;34(4):213
Br J Pharmacol 58(4):483;1976
J Allergy Clin Immunol 57(5):396;1976
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Nippon Yakurigaku Zasshi 74(6):699;1978
Date of Entry
1976/01/01
Revision Date
2021/12/07
tranilast Preferred
tranilast sodium salt Narrower
tranilast hydrate Narrower
MK-341 Narrower
Rizaben Narrower
page delivered in 0.005s